Increased ghrelin sensitivity, decreased leptin concentrations, elevated levels of IL-6 and blood glucose, and hyperactivity of HO neurons (increased cFos immunoreactivity) were observed in cancer mouse models during the development of sleep debris in the late phase of tumor growth (34). This evidence concerns the gene GHRL and cancer.